Latest news

Thumbnail image for Europe’s first allogeneic stem cell therapy rejected by NICE

Europe’s first allogeneic stem cell therapy rejected by NICE

Cost regulators for the NHS in England and Wales have not approved funding for TiGenix and Takeda’s Alofisel - the first allogeneic stem cell therapy to be approved for use across the European Union – for use in Crohn’s patients in draft guidelines.

20th August 2018

Thumbnail image for Cases of type II diabetes surge in under-25s

Cases of type II diabetes surge in under-25s

The number of children and young people being treated for type II diabetes has leapt by around 40 percent in just four years to more than 700 cases, NHS data show.

20th August 2018

Thumbnail image for Don’t miss the 7 September deadline

Don’t miss the 7 September deadline

The PharmaTimes Sales Awards closes for entry in just a few weeks and with Sanofi, Allergan, LEO Pharma, Novartis and Bio Products Laboratory and many more besides signed up to take part, all signs are pointing to a very exciting debut indeed. It only takes a few seconds to fill out the online entry form and entrants need not do anything else until the day of the competition.

17th August 2018

Thumbnail image for News of the inaugural Medical & Scientific Excellence Awards is spreading fast

News of the inaugural Medical & Scientific Excellence Awards is spreading fast

With the importance of MSLs, scientific advisors and medical information professionals growing year on year - PharmaTimes Media has recognised this burgeoning area and gathered together an array of experts within the field to devise a challenging and rewarding competition that now includes seven categories.

17th August 2018

Thumbnail image for Closing soon - ENTER NOW

Closing soon - ENTER NOW

The prestigious PharmaTimes Marketer of the Year competition closes for entries on 1 September. It only takes a few seconds to fill out the online entry form and then you don’t need to do anything else until the day of the competition. This year is extra special as the competition is celebrating its 25th anniversary - and we don't want you to miss out.

17th August 2018

Thumbnail image for Novo buys UK group Ziylo

Novo buys UK group Ziylo

Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out based at Unit DX science incubator in Bristol, UK.

17th August 2018

Thumbnail image for Enter now for a place in history

Enter now for a place in history

It's a double first for the Communications Team of the Year competition, as individuals within agencies and pharma companies battle it out for the 'Aspiring Communications Manager of the Year' title.

17th August 2018

Thumbnail image for Teva, Regeneron’s fasinumab hits osteoarthritis goals

Teva, Regeneron’s fasinumab hits osteoarthritis goals

Teva and Regeneron Pharmaceuticals have unveiled positive topline results from a Phase III study assessing the safety and efficacy of fasinumab in patients with chronic pain from osteoarthritis (OA) of the knee or hip.

17th August 2018

Thumbnail image for Lenvima wins green light in liver cancer

Lenvima wins green light in liver cancer

Eisai and MSD’s Lenvima (lenvatinib) has been approved in the US for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC).

17th August 2018

Thumbnail image for Ortho resubmits Duobrii in the US

Ortho resubmits Duobrii in the US

Bausch Health group Ortho Dermatologics has resubmitted an application to market its plaque psoriasis lotion Duobrii in the US

16th August 2018

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download